No abstract

Bevacizumab treatment is associated with a significantly increased risk of developing GI perforation, and clinicians should be aware of the risks of GI perforation with the administration of this drug in cancer patients.

Efficacy of EFGR TKIs Monotherapy in Comparison with Standard Second-line Chemotherapy for Advanced NSCLCAsian Pacific J Cancer Prev, 13 (10), 5177-5182 IntroductionLung cancer is still a leading cause of cancer-related deaths worldwide with a 5-year survival of less than 15% (Parkin et al., 2002;Schiller et al., 2002;. Because the majority of people diagnosed with non-small cell lung cancer (NSCLC) are unsuitable for surgery, chemotherapy remains the cornerstone of treatment and prolongs survival with a positive impact on quality of life. However, the majority of patients with advanced NSCLC experience cancer progression after 3-6 months of first-line chemotherapy, and approximately 40% of them have progressive disease during the treatment

Our preliminary results suggest that ADC vales measurement may be a useful imaging biomarker for prediction and early assessment of therapeutic response of prostate cancer to CIRT.